Search research articles
Contact Us
Filters
Showing results (31-40 of 99) with videos related to
Page
of 10
Sort By:
Annals of Internal Medicine
|
June 21, 2006
Dogma disputed: can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous?
Franz H Messerli, Giuseppe Mancia, C Richard Conti, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
June 27, 2025
Participant, site personnel and sponsor perspectives on decentralized trial features in COURAGE-ALS: a randomized clinical trial
Stacy A Rudnicki, Paulos Gebrehiwet, Stuart Kupfer, et al.
Journal of the American College of Cardiology
|
January 8, 2011
Lowering the triglyceride/high-density lipoprotein cholesterol ratio is associated with the beneficial impact of pioglitazone on progression of coronary atherosclerosis in diabetic patients: insights from the PERISCOPE (Pioglitazone Effect on Regression of Intravascular Sonographic Coronary Obstruction Prospective Evaluation) study
Stephen J Nicholls, E Murat Tuzcu, Kathy Wolski, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)
|
May 12, 2017
Evaluation of the angiotensin II receptor blocker azilsartan medoxomil in African-American patients with hypertension
Wallace Johnson, William B White, Domenic Sica, et al.
Thrombosis and Haemostasis
|
March 28, 2014
Phase 2 study of TAK-442, an oral factor Xa inhibitor, in patients following acute coronary syndrome
Sidney Goldstein, Eric R Bates, Deepak L Bhatt, et al.
Heart Failure Reviews
|
April 21, 2015
Clinical trials in hospitalized heart failure patients: targeting interventions to optimal phenotypic subpopulations
Muthiah Vaduganathan, Javed Butler, Lothar Roessig, et al.
Thrombosis and Haemostasis
|
January 17, 2003
Acute thrombocytopenia in patients treated with the oral glycoprotein IIb/IIIa inhibitors xemilofiban and orbofiban: evidence for an immune etiology
Jacqueline A Brassard, Brian R Curtis, Richard A Cooper, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
January 18, 2018
Kidney Biomarkers and Decline in eGFR in Patients with Type 2 Diabetes
Katherine G Garlo, William B White, George L Bakris, et al.
Heart Failure Clinics
|
July 2, 2013
Recognizing hospitalized heart failure as an entity and developing new therapies to improve outcomes: academics', clinicians', industry's, regulators', and payers' perspectives
Mihai Gheorghiade, Ami N Shah, Muthiah Vaduganathan, et al.
Clinical and Translational Science
|
March 5, 2026
Clinical Evaluation of Drug-Drug Interactions With Aficamten
Neha Maharao, Donghong Xu, Punag Divanji, et al.
Page
of 10
Search research articles
Search
Showing results (31-40 of 99) with videos related to
Sort By:
Page
of 10
Annals of Internal Medicine
|
June 21, 2006
Dogma disputed: can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous?
Franz H Messerli, Giuseppe Mancia, C Richard Conti, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
June 27, 2025
Participant, site personnel and sponsor perspectives on decentralized trial features in COURAGE-ALS: a randomized clinical trial
Stacy A Rudnicki, Paulos Gebrehiwet, Stuart Kupfer, et al.
Journal of the American College of Cardiology
|
January 8, 2011
Lowering the triglyceride/high-density lipoprotein cholesterol ratio is associated with the beneficial impact of pioglitazone on progression of coronary atherosclerosis in diabetic patients: insights from the PERISCOPE (Pioglitazone Effect on Regression of Intravascular Sonographic Coronary Obstruction Prospective Evaluation) study
Stephen J Nicholls, E Murat Tuzcu, Kathy Wolski, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)
|
May 12, 2017
Evaluation of the angiotensin II receptor blocker azilsartan medoxomil in African-American patients with hypertension
Wallace Johnson, William B White, Domenic Sica, et al.
Thrombosis and Haemostasis
|
March 28, 2014
Phase 2 study of TAK-442, an oral factor Xa inhibitor, in patients following acute coronary syndrome
Sidney Goldstein, Eric R Bates, Deepak L Bhatt, et al.
Heart Failure Reviews
|
April 21, 2015
Clinical trials in hospitalized heart failure patients: targeting interventions to optimal phenotypic subpopulations
Muthiah Vaduganathan, Javed Butler, Lothar Roessig, et al.
Thrombosis and Haemostasis
|
January 17, 2003
Acute thrombocytopenia in patients treated with the oral glycoprotein IIb/IIIa inhibitors xemilofiban and orbofiban: evidence for an immune etiology
Jacqueline A Brassard, Brian R Curtis, Richard A Cooper, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
January 18, 2018
Kidney Biomarkers and Decline in eGFR in Patients with Type 2 Diabetes
Katherine G Garlo, William B White, George L Bakris, et al.
Heart Failure Clinics
|
July 2, 2013
Recognizing hospitalized heart failure as an entity and developing new therapies to improve outcomes: academics', clinicians', industry's, regulators', and payers' perspectives
Mihai Gheorghiade, Ami N Shah, Muthiah Vaduganathan, et al.
Clinical and Translational Science
|
March 5, 2026
Clinical Evaluation of Drug-Drug Interactions With Aficamten
Neha Maharao, Donghong Xu, Punag Divanji, et al.
Page
of 10